▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2390 by analyst upside · 2026-10-16
VMD
Viemed Healthcare, Inc.
Healthcare · Market Cap $371M · P/E 27.1x
ANALYST PRICE TARGET
+28.2%
implied upside to consensus target
Current Price $9.75
Consensus Target $12.5
Bull Target $14.0
Bear Target $11.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
0
Hold
1
Sell
0
52-Week Low $6.05
52-Week High $12.61
YTD Return +35.0%
FUNDAMENTALS
Market Cap $371M
P/E Ratio (TTM) 27.1x
Forward P/E 24.4x
EPS (TTM) $0.36
PEG Ratio 2.42
Dividend Yield N/A
Revenue (TTM) $302M
Profit Margin 4.8%
52-WEEK RANGE
52-Week Low $6.05
52-Week High $12.61
Current Price $9.75
Bear Target $11.0
Bull Target $14.0
● Now $9.75 ● Target $12.5
TRADING DATA
Avg Volume 345K
YTD Return +35.0%
Analyst Count 2
Consensus Buy
Upside to Target +28.2%
Last Updated 2026-10-16

ANALYST SUMMARY

Viemed Healthcare, Inc. (VMD) is currently trading at $9.75 with a Wall Street consensus price target of $12.5, implying potential upside of 28.2% over the next 12 months. 2 analysts currently cover VMD, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $14.0, while the most cautious has a target of $11.0.

VMD operates in the Healthcare sector with a market capitalisation of $371M. The stock is up 35.0% year-to-date and is currently trading near the upper end of its 52-week range of $6.05 – $12.61.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barrington Research ● Initiated
Outperform 2026-08-24 Building track record
Freedom Broker ↓ Downgrade
Buy → Hold 2026-08-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
8/30
Consensus clarity
24/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →